The genetic test reveals predispositions in how efficiently your GLP-1 receptors signal, how your body regulates energy expenditure, and how you metabolize glucoseall factors that operate independently of estrogen but influence your potential response to semaglutide during menopause
barrier or non-oral contraceptive methods are recommended for 4 weeks after initiation and following each dose increase
Retatrutide is not yet FDA approved, but like many GLP-1 agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide), retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
Glutathione, Lysine, 2x Vitamin C, Toradol*, B12, Zinc Nourish your skin from within for a healthy, youthful glow